Preoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass

Experimental and Clinical Cardiology

Volumn 17, Issue 3, 2012, Pages 125-130

  Levin, Ricardo ^a   Degrange, Marcela ^b   Del Mazo, Carlos ^c   Tanus, Eduardo ^c   Porcile, Rafael ^d  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Navy Central Hospital   (Argentina)

^c and PANLAR Axial Spondyloarthritis and Psoriatic Arthritis Study Group   (Argentina)

^d UNIVERSIDAD ABIERTA INTERAMERICANA   (Argentina)

Author keywords

Cardiac surgery; Hemodynamic optimization; Inotropic agents; Levosimendan; Postoperative low cardiac output

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPERTENSIVE AGENT; INOTROPIC AGENT; LEVOSIMENDAN; PLACEBO;

ADULT; ARTICLE; CARDIAC PATIENT; CARDIOPULMONARY BYPASS; CARDIOVASCULAR MORTALITY; CONTINUOUS INFUSION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART OUTPUT; HIGH RISK PATIENT; HUMAN; INCIDENCE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE TREATMENT;

EID: 84867485658     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Rao V, Ivanov J, Weisel RD, Ikonomidis JS, Christakis GT, Tirone D. Predictors of low cardiac output syndrome after coronary artery bypass. J Thorac Cardiovasc Surg 1996;112:38-51. (Pubitemid 26268967)
2. Ascione R, Narayan P, Rogers CA, Lim KHH, Capoun R, Angelini GD. Early and midterm clinical outocome in patients with severe left ventricular dysfunction undergoing coronary artery surgery. Ann Thorac Surg 2003;76:793-800.
3. Silva Guisasola J, Gonzalez Santos J, Ruiz Fernandez M, et al. Disfuncion ventricular isquemica cronica severa. Determinantes del riesgo quirurgico y del resultado clinico a largo plazo. Rev Esp Cardiol 1997;50:870-81. (Pubitemid 127517348)
4. Smedira NG, Blackstone EH. Postcardiotomy mechanical support: Risk factors and outcomes. Ann Thorac Surg 2001;71:S60-S66. (Pubitemid 32216190)
5. Shapira OM, Hunter CT, Anter A, et al. Coronary artery bypass grafting in patients with severe left ventricular dysfunction: Early and mid-term outcomes. J Card Surg 2006;21:225-31.
6. Ferguson TB, Hammill BG, Peterson ED, DeLong ER, Grover FL. A decade of change-risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: A report from the STS National Database Committee and the Duke Clinical Research Institute. Ann Thorac Surg 2002;73:480-90.
7. Christenson JT, Simonet F, Badel P, Schmuziger M. Optimal timing of preoperative intraaortic balloon pump support in high-risk coronary patients. Ann Thorac Surg 1999;68:934-9. (Pubitemid 29526864)
8. Darwazah AK, Abu Sham'a RA, Hussein H, Hawari MH, Ismail H. Myocardial revascularization in patients with low ejection fraction <35%: Effect of pump technique on early morbidity and mortality. J Card Surg 2006;21:22-7.
9. Alvarez J, Bouzada M, Fernandez AL, et al. Comparacion de los efectos hemodinamicos del levosimendan con la dobutamina en pacientes con bajo gasto despues de cirugia cardiaca. Rev Esp Cardiol 2006;59:338-45. (Pubitemid 43833838)
10. Levin RL, Degrange MA, Porcile R, et al. Superioridad del sensibilizante al calcio levosimendan comparado con dobutamina en el sindrome de bajo gasto cardiaco postoperatorio. Rev Esp Cardiol 2008;61:471-9. (Pubitemid 351930598)
11. Antoniades C, Tousoulis D, Koumallos N, Marinou K, Stefanadis C. Levosimendan: Beyond its simple inotropic effect in heart failure. Pharmacol Ther 2007;114:184-97. (Pubitemid 46561532)
12. De Luca L, Colucci WS, Nieminen MS, Massie BM, Gherghiade M. Evidence-based use of levosimendan in different clinical settings. Eur Heart J 2006;27:1908-20. (Pubitemid 44297362)
13. Parissis JT, Rafaouli-Stergiou P, Paraskevaidis I, Mebazaa A. Levosimendan: From basic science to clinical practice. Heart Fail Rev 2007;104:759-61
14. . Meyer K, Klocke RC, Schipke JD, Gams E, Korbmacher B. Ca sensitizer superior to catecholamine during myocardial stunning. Eur J Cardiothorac Surg 2008;34:326-31.
15. Meyer K, Schipke JD, Klocke RC, Gams E, Korbmacher B. Inotropic, vasodilating and preconditioning actions of levosimendan in the heart. Thorac Cardiovasc Surg 2008;56:379-85.
16. Barraud D, Faivre V, Damy T, et al. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: Comparison with dobutamine and milrinone. Crit Care Med 2007;35:1376-82. (Pubitemid 46642669)
17. Dernellis J, Panaretou M. Effects of levosimendan on restrictive left ventricular filling in severe heart failure. Chest 2005;128:2633-9.
18. Tritapepe L, De Santis V, Vitale D, et al. Levosimendan pretreatment improves outcomes in patients undergoing coronary artery bypass graft surgery. Br J Anaesth 2009;102:198-204.
19. Kurt IH. Use of levosimendan in patients with ischemic heart disease following mechanical reperfusion. Surg Today 2009;39:381-6.
20. Parissis JT, Andreadou I, Bistola V, Paraskevaidis I, Filipattos G, Kremastinos DT. Novel biologic mechanisms of levosimendan and its effect on the failing heart. Expert Opin Investig Drugs 2008;17:1143-50.
21. Pagel PS. Levosimendan in cardiac surgery: A unique drug for the treatment of perioperative left ventricular dysfunction or just another inodilator searching for a clinical application? Anesth Analg 2007;104:759-61. (Pubitemid 46548292)
22. Parissis JT, Adamopoulos S, Antoniades C, et al. Effects of levosimendan on circulating proinflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure. Am J Cardiol 2004;93:1309-12. (Pubitemid 38595693)
23. Paraskevaidis IA, Parissis JT, Kremastinos D. Anti-inflammatory and anti-apoptotic effects of levosimendan in decompensated heart failure: A novel mechanism of drug-induced improvement in contractile performance of the failing heart. Curr Med Chem Cardiovasc Hematl Agent 2005;3:243-7. (Pubitemid 40974784)
24. 2+ sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine. Eur J Heart Fail 2005;7:882-7.
25. Liu T, Li G, Xu G. Levosimendan may prevent postoperative atrial fibrillation through anti-inflammatory and antioxidant modulation. J Cardiothorac Vasc Anesth 2009;23:757-8.
26. Landoni G, Mizzi A, Biondi-Zoccai G, et al. Reducing mortality in cardiac surgery with levosimendan: A meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth 2010;24:51-57.
27. Maharaj R, Metaxa V. Levosimendan and mortality after coronary revascularisation: A metaanalysis of randomised controlled trials. Crit Care 2011;15:R140.
28. Tritapepe L, De Santis V, Vitale D, et al. Preconditioning effects of levosimendan in coronary artery bypass grafting-a pilot study. Br J Anaesth 2006;96:694-700. (Pubitemid 43786683)
29. De Hert SG, Lorsomradee S, Cromheecke S, Van der Linden PJ. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anesth Analg 2007:104:766-73. (Pubitemid 46548294)
30. Tasouli A, Papadoupolos K, Antoniou T, et al. Efficacy and safety of perioperative infusion of levosimendan in patient with compromised cardiac function undergoing open-heart surgery: Importance of early use. Eur J Cardiothorac Surg 2007;32:629-33. (Pubitemid 47362731)
31. Schoemaker WC, Appel PL, Kram HB, Waxman K, Lee TS. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 1988;94:1176-86. (Pubitemid 19002776)
32. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-77.
33. Zangrillo A, Biondi-Zoccai G, Mizzi A, et al. Levosimendan reduces cardiac troponin release after cardiac surgery: A meta-analysis of randomized controlled studies. J Cardiothorac Vasc Anesth 2009;23:474-8.
34. De Santis V, Vitale D, Tritapepe L. Levosimendan and cardiac surgery. J Cardiothorac Vasc Anesth 2010;24:210.